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ABSTRACT 
 
Background: In Africa, women tested for HIV during antenatal care are counselled to share with their 
partner their HIV-test result and to encourage partners to undertake HIV-testing. We investigate, 
among women tested for HIV within a prevention of mother-to-child transmission of HIV (PMTCT) 
programme, the keys moments for disclosure of their own HIV-status to their partner and the impact 
on partner HIV-testing. 
Methods and findings: Within the Ditrame Plus PMTCT project in Abidjan, 546 HIV-infected and 
393 HIV-negative women were tested during pregnancy and followed-up for two years after delivery. 
Circumstances, frequency and determinants of disclosure to the male partner were estimated according 
to HIV-status. The determinants of partner HIV-testing were identified according to women’s HIV-
status. During the two-year follow-up, disclosure to the partner was reported by 96.7% of the HIV-
negative women, compared to 46.2% of HIV-infected women (χ²=265.2, df=1, p<0.001). Among 
HIV-infected women, privileged circumstances for disclosure were just before delivery, during early 
weaning (at 4 months to prevent HIV postnatal transmission) or upon resumption of sexual activity. 
Formula feeding by HIV-infected women increased the probability of disclosure (adjusted odds ratio: 
1.54, 95% confidence interval: 1.04-2.27, Wald test=4.649, df=1, p=0.031) whereas household factors 
such as having a co-spouse or living with family reduced the probability of disclosure. The proportion 
of male partners HIV-tested was 23.1% among HIV-infected women and 14.8% among HIV-negative 
women, respectively (χ²=10.04, df=1, p=0.002). Partners of HIV-infected women who were informed 
of their wife’s HIV-status were more likely to undertake HIV-testing than those not informed (37.7% 
versus 10.5%, χ²=56.36, df=1, p<0.001). 
Conclusions: In PMTCT programmes, specific psycho-social counselling and support should be 
provided to women during the key moments of disclosure of HIV-status to their partners (end of 
pregnancy, weaning, and resumption of sexual activity). This could contribute to improving 
compliance with the advice given to prevent postnatal and sexual HIV transmission. 
 
Key words: Prenatal HIV-testing, Africa, women, disclosure, male partner HIV-testing.
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Introduction 
 
At the end of 2006, 63% of all people living with HIV/AIDS lived in sub-Saharan Africa [1]. 
Programmatic strategies for the prevention of sexual transmission of HIV need urgent development, 
assessment and scaling-up [2]. In sub-Saharan Africa, prevention should mainly take place within the 
couple. In African countries confronted with an HIV/AIDS pandemic, most cases of sexual 
transmission of HIV occur within stable relationships. In 2006, 59% of HIV-infected adults were 
women [1] and most of them had contracted HIV through sexual transmission from their stable partner 
[3]. 
Most studies available on sexual relations within the couple have shown lack of sexual prevention 
within stable relationships [4, 5]. The prevention of sexual transmission of HIV within the couple 
involves HIV-testing for each couple member and the systematic use of condoms if one of the couple 
members is HIV-infected or until both couple members have been tested HIV-negative and have 
adopted safe sex practices. Research studies exploring how the risk of sexual transmission of HIV 
infection is managed within couples in sub-Saharan Africa show that these simple principles are 
unfortunately rarely implemented [6-8]. Sexual relations with the regular partner are rarely protected, 
because they are perceived as risk-free sexual relations [4, 5]. Nevertheless, in populations with a high 
prevalence of HIV infection, those who engage in conjugal sexual relations are at risk of infection. 
HIV testing of each partner and conjugal exchange on serostatus remain the only way to evaluate the 
risk of HIV transmission in conjugal sexual relations. But HIV testing has remained infrequent in 
Africa [9]. 
With the implementation of prevention of mother-to-child transmission of HIV (PMTCT) programmes 
in African countries, prenatal HIV counselling and testing is proposed to many pregnant women. 
Hence these women are often the first to be HIV-tested within couples [10]. These women are then 
counselled to share with their partner their own HIV-test result, and they become responsible for 
encouraging their partner to undertake HIV-testing. But the dialogue on sexual activity or HIV/AIDS 
within the couple is not easy, especially when women discover that they are HIV-infected [11-13]. 
Available studies have documented the experience of women’s disclosure to their partner and reported 
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the barriers to disclosure, such as women’s fears related to stigmatisation, to family rejection, to a 
breach of confidentiality or to accusations of infidelity [14]. But these studies did not explore the 
dynamic of the woman’s decision when she informed her partner of her HIV status. Better 
understanding of the circumstances and events leading to women’s disclosure to their partner is 
required, however, in order to better support them in this process. In this paper, we investigated which 
women who accepted HIV-testing within a PMTCT programme reported their HIV-status to their 
partner, and when they did so between HIV testing in pregnancy and 24 months after delivery. We 
also examined whether or not telling the partner had led to HIV testing of the partner. 
 
 
Population and Methods 
 
Ditrame Plus Research Programme 
The ANRS 1201/1202/1253 Ditrame Plus programme was the PMTCT research implemented in 
Abidjan, Côte d’Ivoire in March 2001 [15-17]. HIV testing was systematically proposed at the first 
antenatal consultation (ANC) to all pregnant women aged 18 years or over who attended one of the 
seven antenatal clinics located in two poor, densely populated districts of Abidjan. After signing an 
informed consent form, women were regularly followed-up for two years after delivery, every three 
months during the first year and every six months during the second year. 
Consenting HIV-infected women were systematically invited to be included in a cohort offering 
PMTCT interventions fully described elsewhere [16, 17]: short-course peri-partum antiretroviral 
regimens and exclusive formula feeding from birth until 9 months post-partum or exclusive 
breastfeeding with early cessation at 4 months. A sub-group of HIV-negative pregnant women were 
also included and followed-up in another cohort offering HIV counselling, contraception access and 
access to care. During pre- and post-test counselling and post-partum follow-up, all women were 
informed regarding Sexually Transmitted Infections (STIs) including HIV/AIDS, and the use of 
condom. After delivery, they were also offered postnatal contraception one month after delivery and 
free provision of contraceptives including condoms. 
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HIV-negative and HIV-infected women attended different clinics. During each follow-up visit, 
standardised questionnaires were administered to all women to document the disclosure of HIV-status 
to the partner, the resumption of sexual activity, and socio-demographic characteristics. The same 
standardised questionnaire was used in the two prospective cohorts of HIV-infected and HIV-negative 
women for comparative analysis. 
 
Population 
From March 2001 to June 2003, 980 pregnant women tested for HIV during ANC and having 
delivered were included within the Ditrame Plus programme. The average age of gestation of HIV-
infected pregnant women was 36 weeks [range: 26-43] at enrolment. Twenty-three (2.3%) women lost 
to follow-up before the visit scheduled at one month after delivery and 18 (1.8%) women having 
remained without any partner during the follow-up period were excluded for this analysis. A total of 
939 women, of whom 546 were HIV-infected and 393 HIV-negative, were included for this analysis. 
Ninety per cent of HIV-negative women and 85% of HIV-infected women remained in the study 
through the 18-month post-partum appointment (χ²=6.603, df=1, p=0.010). 
 
Disclosure of HIV-Status to Partner 
We analysed when women disclosed their HIV status to their partner. As the exact date was not 
known, we estimated the disclosure date as the mid-period between the date of the previous follow-up 
visit and the date of the visit when the woman reported having disclosed her status. We then compared 
this period to specific events occurring between prenatal HIV-testing and at the time of resuming 
sexual activity. Specific questions were asked at each visit on the date of resumption of sexual activity 
and the date of cessation of breastfeeding. We analysed the distribution of the disclosure moment 
between HIV-testing and the end of the follow-up, in relation to the delivery, the resumption of sexual 
activity, and weaning by women who chose to breastfeed. Figure 1 illustrates the distribution of the 
time of disclosure, between HIV-testing and the end of the follow-up, in relation to delivery, the 
resumption of sexual activities, and weaning for breastfeeding women. (See appendix for details of 
how the curve was constructed.) 
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Partner’s HIV-Testing 
Only partners HIV-tested in the two years prior to the start of the Ditrame Plus programme or after the 
start of the programme, and whose HIV result was known, were taken into account in this analysis (15 
partners tested for HIV before March 1999 were therefore excluded). The proportion of partners tested 
for HIV was described according to the socio-demographic characteristics of the women, of their 
partner, and of their couple. 
 
Statistical Tools 
Statistical analyses were first performed on all women followed-up and then within each cohort of 
women according to their HIV status. Univariate analyses comprised: variables related to the woman 
(i.e. age, religion, education level, remunerated activity, parity, existence of a co-spouse, type of 
habitat, number of cohabiting family members, HIV status and clinical AIDS stage for HIV-infected 
women, according to the WHO Staging System of HIV Infection and Disease), variables related to the 
partner (i.e. age, education level and HIV status) and variables related to the infant followed-up within 
the project (i.e. infant feeding practice implemented at birth and child survival). Group comparisons 
used non-parametric Mann–Whitney U test for quantitative variables, and χ2 or Fisher’s exact tests for 
qualitative variables. Multivariate logistic regressions were performed and included all variables. All 
statistical analyses were conducted with SPSS for Windows (version 12.0; SPSS Inc.). 
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Results 
 
Characteristics 
Table 1 describes the socio-demographic characteristics of both cohorts of women and their partner. 
HIV-infected women were slightly older than their HIV-negative counterparts, and more often lived 
within a polygamous household (21.8% versus 12.5%, χ²=13.53, df=1, p<0.0001). Male partners were 
on average more educated and older than their wives. All HIV-negative women who delivered live 
infants practiced breastfeeding. Among HIV-infected women, 243 (44.5%) breastfed their infant with 
early cessation at 17 weeks in median (IQR: 13-32), 283 (51.8%) practiced formula feeding, and for 
18 (3.7%) the information was not reported. Among these women, 88.9% of HIV-infected women 
who practiced breastfeeding and 92.5% who practiced formula feeding complied with the choice 
expressed prior to delivery (χ²=2.147, df=1, p=0.143). 
 
Disclosure of Women’s HIV-Status to their Partner 
Most of the HIV-negative women (96.7%) disclosed their HIV-result to their partner, compared to 
46.2% of HIV-infected women (χ²=265.2, df=1, p<0.001). Among HIV-infected women who 
disclosed their HIV status, 82.1% declared that their partner had a “positive” reaction, i.e. was 
understanding and provided moral support. Among the women declaring “negative” reactions from 
their partner after disclosure, 10 (4%) were blamed for not discussing with him prior to HIV-testing, 1 
(0.4%) experienced violence, 6 (2.4%) ended their relation with their partner and 5 (2%) declared their 
partner did not believe their wife’s positive test result. 
 
HIV-infected women were less likely to disclose their HIV status when they lived with their own 
family but without their partner, than when they lived with their partner only (adjusted odds ratio 
[OR]=0.29, confidence interval [95%CI]: 0.17-0.50, Wald test=20.68, df=1: p<0.001) and when they 
had a co-spouse, versus being the only wife (OR=0.51, 95%CI: 0.31-0.83, Wald test=7.19, df=1, 
p=0.007). The probability of disclosing to the partner was higher for HIV-infected women having 
chosen formula feeding compared to those initiating breastfeeding after birth (OR=1.54, 95%CI: 1.04-
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2.27, Wald test=4.649, df=1: p=0.031) (Table 2). No significant correlation was found between 
disclosure and whether or not the woman was engaged in remunerated activity. 
 
The majority of HIV-infected women disclosed their HIV-status to their partner before delivery. 
Among breastfeeding HIV-infected women having disclosed their HIV-status to their partner, 55.7% 
disclosed before delivery, 17% between delivery and the resumption of sexual activity, and 19% 
between delivery and weaning. Among HIV-infected women who did not breastfeed, 65.8% disclosed 
before delivery and 8% disclosed between delivery and resumption of sexual activity. 
Disclosure before delivery was related to child feeding choice: among women having disclosed their 
HIV-status before delivery, 34.6% decided to breastfeed and 64.8% decided not to breastfeed prior to 
delivery (χ²=12.35, df=1, p<0.001).  
Among the women who disclosed after delivery, we observed peaks of disclosure just around the 
period of weaning and around the resumption of sexual activity (Fig. 1). 
 
Partners’ HIV-Testing 
Overall, 184 (19.6%) partners were tested for HIV. Partners of HIV-infected women were more likely 
to be tested than partners of HIV-negative women (23.1% versus 14.8%, χ²=10.04, df=1, p=0.002). 
Among the 184 couples HIV-tested, 54 (29.4%) were seroconcordant HIV-infected, 56 (30.4%) were 
seroconcordant HIV-negative and 74 (40.2%) were serodiscordant couples. In the serodiscordant 
couples, two women were HIV-negative and 72 women were HIV-infected. 
 
For partners of HIV-negative women, demographic variables such as education and marital status 
(monogamous or polygamous) were not correlated with HIV-testing (Table 3). The only variable 
significantly associated to partner HIV-testing was previous HIV testing of the partner, (44.4% versus 
14.1%, χ²=6.452, df=1, p=0.011). For partners of HIV-infected women, on the other hand, partners 
were more likely to be tested if they were educated (46.3% versus 16.7%, χ²=12.12, df=1, p<0.001), 
informed of their wife’s infection (37.7% versus 10.5%, χ²=56.36, df=1, p<0.001), in monogamous 
couples (27.6% versus 6.7%, χ²=22.93, df=1, p<0.001), and if they had previous HIV-testing 
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experience (100% versus 22%, χ²=20.22, df=1: p<0.001). 
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Discussion 
In this study, almost all (96.7%) women who had been informed of their HIV-negative status notified 
their partner. Among HIV-infected women, less than half (46.2%) had disclosed to their partner at the 
end of the follow-up period. We have also highlighted the existence of three privileged moments for 
HIV-infected women’s disclosure to their partner: before delivery, upon resumption of sexual activity, 
and around early weaning for breastfeeding women. For HIV-negative women, we had already 
described in a previous study that most of them informed their partner of their testing before delivery 
[7]. Only one in five male partners were tested for HIV. Partners informed of their wife’s HIV-status 
were more likely to undertake HIV-testing, in particular among HIV-infected women. 
 
This study was conducted within a population of women participating in a research programme 
proposing systematic prenatal HIV-testing and counselling but not in the operational context of 
PMTCT services delivery. The psychosocial support of women in our study may have been stronger 
than in an operational context. Hence the proportions of women who disclosed their HIV-status to 
their partner and the proportion of partners HIV-tested may be higher than those obtained in an 
operational context. Another weakness is that we did not study the partner's reaction over a long 
period of time. Hence the negative reactions of partners may be underestimated. However, two studies 
reported in Tanzania and Burkina Faso had previously showed that after sharing information, the male 
partners proved to be understanding and the majority of the couples remained stable [19, 20]. Despite 
these weaknesses, our prospective study design provides reliable and original information on the 
timing of when women disclose their HIV-status to their partner. Our timing data were very precise 
before delivery (66% of disclosure) because women were seen every other week. After delivery, 
women were only seen every three months and data were less precise, but even in this period we had 
precise information on the relative position of the different events: disclosure, resumption of sexual 
activity, and weaning. 
 
Our results reveal that, in spite of the continuous counselling and psychosocial support provided 
within the Ditrame-Plus programme, the proportion of HIV-infected women having disclosed their 
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status to their partner is comparable to what had been observed in the context of a previous PMTCT 
research programme conducted on the same sites in Abidjan and with no specific support by the socio-
medical team for notifying the partner [18]. This lack of evolution over time underlines the difficulties 
HIV-infected women encounter in discussing their own HIV-status within the couple and raises the 
persistent fear of social stigma associated with HIV in this context. Nevertheless, these HIV-infected 
women declared during qualitative interviews published elsewhere [8] that disclosing their status to 
their partner seemed essential to them, so the women could benefit from comfort and support to make 
important decisions for their infant and their couple. Most (82%) of the partners of HIV-infected 
women informed were understanding and provided their wife with moral support. Negative reactions 
of the male partner (violence, separation) existed but they were rare. 
 
The analysis of disclosure over time showed that two-thirds of the HIV-infected women who disclosed 
their HIV-status to their partner reported they did so before delivery. This result may be related to the 
fact that during pregnancy, women were asked to say how they intended to feed the child they were 
carrying, i.e., formula feeding from birth or exclusive breastfeeding with early cessation at four 
months. Two thirds (64.8%) of women who had disclosed their HIV-status before delivery had opted 
for formula feeding, versus 50% among women who did not disclose before delivery. Indeed, in this 
context where breastfeeding is widely practiced and prolonged [21], it was important for HIV-infected 
women opting for formula feeding to receive their partner’s support. Hence they were more likely to 
disclose their HIV-status before delivery, i.e. before implementation of the infant feeding choice. This 
is an important factor to take into account in the prevention of MTCT. Similarly, for women who 
breastfed their child at birth, the period around weaning appeared to be a critical moment for 
disclosure to the partner [22]. The median duration (4 months) of total breastfeeding among HIV-
infected women in the Ditrame Plus study was considerably shorter than what was previously 
described in Abidjan where median duration was estimated to be around 17 months [21]. In the 
Ditrame Plus programme, we observed that failure of early weaning was linked to pressure from the 
woman’s family-in-law. [17]. Breastfeeding HIV-infected women who had not disclosed their HIV-
status before delivery may have chosen to do so at weaning time, in order to justify early weaning to 
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the partner and get his support in front of the family and community. An earlier study conducted in 
Abidjan and Bobo-Dioulasso noted that the partner’s opinion was the first obstacle to adoption of safe 
infant feeding practices to prevent HIV transmission through breastfeeding [23]. The implementation 
of alternatives to prolonged breastfeeding for PMTCT depends highly on the conjugal and social 
environment of each HIV-infected woman. 
 
Finally, a third event appeared to be essential in the disclosure process, the resumption of sexual 
activity after delivery. When women were informed of their HIV infection, they received counselling 
on preventing transmission via sexual relations. When they resume sex, proposing the use of condoms 
to their partner is complex and arouses suspicion if the partner is unaware of his wife’s HIV status. 
Disclosing her HIV infection may seem necessary to avoid HIV transmission within their couple. 
At these key moments for disclosure that we identified, the psychosocial support for women may be 
intensified, in order to increase the proportion of women who manage to disclose their HIV-status to 
their partner. The women who would benefit from such support around disclosure are those who 
encounter difficulties in the present programme in talking with their partner, i.e., mainly the youngest 
women with less conjugal experience, and those whose living conditions are not suitable for conjugal 
confidentiality (shared housing, no co-residence with the male partner, or presence of a co-spouse). 
Conjugal organisation seems to be an important determinant of disclosure. Women co-habiting with 
their partner were more likely to share their test result, regardless of their HIV status. Similar results 
were observed in a Zambian study on individual and couple HIV counselling and testing [24]. 
Cohabitation indeed provides more space and time for discussing such sensitive issues as HIV 
infection. By contrast, living in polygamous households or in shared housing reduces the likelihood of 
women’s disclosure, probably due to reduced confidentiality. It seems that women who do not live 
with their partner and/or who have a co-spouse are less likely to trust their partner. 
Only 19.6% of male partners were tested for HIV. The programme did not offer any couple HIV-
counselling and testing, but free HIV counselling and testing were available to any willing partner. 
Three reasons may explain the small proportion of men tested for HIV [7]: the fear of discovering his 
HIV-positive status; the need for him to personally and actively request HIV-testing (unlike pregnant 
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women, who were offered HIV counselling and testing during antenatal care); and the belief that he 
had the same HIV-status as his wife. The third reason, i.e., the belief that couples cannot be 
serodiscordant, may explain why only 14.8% male partners of HIV-negative women were tested. A 
similar result was found in Tanzania: only 16% of partners informed of their wife’s HIV-status said 
they would like to go for testing [11].  
 
Partners’ HIV-testing was significantly correlated to their previous HIV-testing experience, in addition 
to others factors such as education level and sharing of woman’s HIV-test result. Earlier experience 
with HIV testing seems to diminish the fear associated with the test, so it would be valuable to 
multiply the occasions to be HIV-tested. 
 
In conclusion, our study suggests that the implementation of specific psychosocial counselling and 
support for HIV-infected women at the end of pregnancy, the period of early weaning, and the 
resumption of sexual activity is important to help women to disclose their HIV-status to their partner. 
This disclosure is an important step which could contribute to improving women's compliance with the 
advice given to prevent postnatal and sexual HIV transmission. 
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Appendix 
1- Construction of curves of Figure 1 
On these two curves we situated disclosure of the woman’s HIV-status to her partner during the period 
between HIV-testing and the end of the follow-up. During this period the disclosure moment is related 
to the delivery, the resumption of sexual activity and the weaning of the child for breastfeeding 
women, in term of anteriority/posteriority and duration. On this time scale specific to each woman, the 
disclosure moment is located between HIV-testing and delivery, if disclosure occurred before delivery. 
If it occured between delivery and the end of follow-up, it is located in regard to weaning (Fig. 1a) or 
resumption of sexual activity (Fig. 1b). Resulting curves show frequencies of these relative moments. 
This graphical construction allows to characterise the distribution of the disclosure moments in 
relation with three key peri- or postpartum events: the delivery, the resumption of sexual activity and 
the weaning of the child for breastfeeding women. 
 
Figure 1a: For each woman, the follow-up is scaled according to four specific moments: d0 date of 
announcement of the HIV-test result to the woman; d1 date of delivery (or end of pregnancy); d2 date 
of weaning; df date of end of follow-up. The abscissa of the moment at which the woman disclosed her 
HIV-status to her partner (d) is estimated according to these moments, using a ratio r calculated as 
follows: 
If disclosure before delivery:  r = (d- d1) / (d1 – d0) ⇒  -1 ≤ r ≤ 0. 
If disclosure after delivery:  r = (d - d1) / (d2 – d1) ⇒ 0 ≤ r. 
Hence, for each woman: d0 on abscissa (-1), d1 on abscissa (0), d2 on abscissa (1), the disclosure 
moment on abscissa (r), which can take values comprised between -1 (disclosure happened at the same 
time as announcement) and 90 (disclosure happened at the end of follow-up and weaning happened 
one week after delivery). On ordinate, we indicate the proportion of women having disclosed their 
status to their partners, calculated for each step of 0.2 until r = 2. After r = 2, the step is increased and 
the proportion of women having disclosed their status to their partners is adjusted according to the 
step. Then the slope was smoothed. 
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Figure 1b: same as above, with the date of resumption of sexual activity instead of the date of 
weaning. 
 
2- Members of the ANRS 1201-1202-1253 Ditrame Plus Study Group 
Medical team: 
Principal Investigators: François Dabis, Valériane Leroy, Marguerite Timite-Konan, Christiane 
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Coordination in Abidjan: Laurence Bequet, Didier K. Ekouevi, Besigin Tonwe-Gold, Ida Viho. 
Methodology, biostatistics and data management: Gérard Allou, Renaud Becquet, Katia Castetbon, 
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Table 1. Socio-demographics characteristics of women at enrolment according to their HIV-status (Ditrame Plus 
ANRS 1201-1202-1253, Abidjan, 2001-2005) 
 
HIV-infected women 
N=546 
HIV-negative women 
N=393 
p * 
Overall 
N=939 
Median age in years (IQR) 26 (23 - 30) 25 (22 - 29) 0.002 ¶ 26 (22 - 30) 
Median number of children alive at time of study (IQR) 2 (1 – 3) 2 (1 – 3) 0.371 ¶ 2 (1 - 3) 
Education level (%)     
No education 196 (35.9) 123 (31.3) 0.148 319 (34.0) 
Primary 206 (37.7) 145 (36.9)  351 (37.4) 
Secondary and above 144 (26.4) 125 (31.8)  269 (28.6) 
Religion (%)     
Christian 303 (55.5) 241 (61.3) 0.025 544 (57.9) 
Muslim 187 (34.2) 130 (33.1)  317 (33.8) 
Animist or no religion 56 (10.3) 22 (5.6)  78 (8.3) 
Cohabiting with (%)     
Partner only 210 (38.5) 123 (31.3) 0.001 333 (35.5) 
Partner and family 166 (30.4) 147 (37.4)  313 (33.3) 
Family or family-in-law 146 (26.7) 119 (30.3)  265 (28.2) 
Other, no partner 24 (4.4) 4 (1.0)  28 (3.0) 
Declaring at least one co-spouse (%) 119 (21.8) 49 (12.5) <0.001 168 (17.9) 
Having remunerated activity (%) 280 (51.2) 179 (45.5) 0.083 459 (48.9) 
Living in shared housing † (%) 358 (65.6) 224 (57.0) 0.008 582 (62.0) 
Choice of child feeding at birth prior delivery (%)     
Breast-feeding 241 (44.1) NC - - 
Formula feeding 300 (55.0)    
No choice 5 (0.90)    
Partner’s age (%) n=194 n=367  n=561 
20 – 29 years 50 (25.8) 99 (27.0) 0.836 149 (26.6) 
30 – 39 years 105 (54.1) 189 (51.5)  294 (52.4) 
40 years and above 39 (20.1) 79 (21.5)  118 (21.0) 
Partner’s level of education (%) n=202 n=373  n=575 
No education 42 (20.8) 70 (18.8) 0.487 112 (19.5) 
Primary 25 (12.4) 54 (14.5)  79 (13.7) 
Secondary 100 (49.5) 199 (53.3)  299 (52.0) 
Higher education 35 (17.3) 50 (13.4)  85 (14.8) 
IQR, interquartile range. *Comparison HIV-infected /HIV-negative, χ² test or ¶Mann Whitney U-test. †Typical housing in Abidjan with 
several houses organized around a yard, where inhabitants share kitchen and restroom and live in crowded accommodations. NC, not 
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Table 2. Determinants of women’s HIV-status disclosure to partners, among HIV-infected women. Univariate analysis 
and multivariate logistic regression. (Ditrame Plus ANRS 1201-1202-1253, Abidjan, 2001-2005)  
N = 546 
Women having disclosed 
their status to partners 
 Multivariate analysis § 
Variables 
n % p*  aOR# 95% CI p** 
Age (years)   0.015    0.110 
18-19 31 22.6   1 -  
20-24 167 41.9   1.62 0.61-4.31 0.331 
25-29 193 47.7   2.03 0.75-5.46 0.162 
30-34 106 55.7   3.09 1.07-8.90 0.036 
35 and above 49 49.0   2.94 0.93-9.32 0.066 
Education level   0.308    0.810 
No education 196 42.3   1 -  
Primary 206 46.6   1.06 0.67 – 1.68 0.800 
Secondary and above 144 50.7   1.19 0.70 – 2.02 0.520 
Religion   0.659    0.799 
Christian 303 47.9   1 -  
Muslim 187 44.4   1.16 0.74 – 1.82 0.515 
Animist or no religion 56 42.9   1.10 0.58 – 2.08 0.765 
Cohabiting with   <0.001    <0.001 
Partner only 210 55.2   1 -  
Partner and family 166 51.8   0.89 0.57-1.40 0.637 
Family or family-in-law 146 26.7   0.29 0.17-0.50 <0.001 
Other 24 45.8   0.64 0.25-1.64 0.355 
Declaring at least one co-spouse   <0.001     
No 427 50.1   1 -  
Yes 119 31.9   0.51 0.31-0.83 0.007 
Living in shared housing †   0.010     
No 188 53.7   1 -  
Yes 358 46.0   0.67 0.44-1.02 0.067 
Having remunerated activity   0.968     
No 266 46.2   1 -  
Yes 280 46.1   1.15 0.78 – 1.69 0.471 
Number of infants alive   0.955     
≤ 1 177 46.3   1 -  
> 1 369 46.1   0.67 0.42 – 1.06 0.086 
Clinical AIDS stage   0.756    0.763 
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Stage 1 189 47.6   1 -  
Stage 2 215 44.2   0.867 0.56 – 1.34 0.520 
Stage 3 or 4 142 47.2   0.855 0.52 – 1.40 0.534 
Infant feeding mode at birth of index infant §   0.005     
Breastfeeding 243 39.1   1 -  
Formula feeding 283 51.2   1.54 1.04-2.27 0.031 
Death of index infant   0.625     
No 487 45.8   1 -  
Yes 59 49.2   1.13 0.55 – 2.29 0.727 
 
* χ2 test. § 20 women whose data are not available were excluded for analysis. # aOR, adjusted odds ratio. CI, confidence interval. ** Wald 
test. † Typical housing in Abidjan with several houses organized around a yard, where inhabitants share kitchen and restroom and live in 
crowded accommodations. 
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Table 3. Proportions of male partners tested for HIV according to women’s HIV-status (Ditrame Plus ANRS 1201-
1202-1253, Abidjan, 2001-2005) 
 HIV-infected women  HIV-negative women 
Variables 
 
N = 546 
Partner tested 
(%) 
 
p * 
 
 
N = 393 
Partner tested 
(%) 
 
p * 
Woman’s education level        
No education 196 16.3 0.003  123 13.0 0.235 
Primary 206 23.3   145 12.4  
Secondary and above 144 31.9   125 19.2  
Woman has a co-spouse        
No 427 27.6 <0.001  344 14.8 0.921 
Yes 119 6.7   49 14.3  
Woman lives with her  partner        
No 170 13.5 <0.001  123 12.2 0.334 
Yes 376 27.4   270 15.9  
Partner’s education level †        
No education 42 16.7 <0.001  70 8.6 0.074 
Primary and above 160 46.3   303 17.2  
Partner knows woman’s HIV status        
No 294 10.5 <0.001  13 0 - 
Yes 252 37.7   380 15.3  
Woman‘s partner previously tested for HIV        
No 540 22.0 
 
<0.001 
 384 14.1 
 
0.030 
Yes 6 100   9 44.4  
 
† Data are not available for 344 HIV-infected women and 20 HIV-negative women. N, number. * χ2 or Fisher's exact tests. 
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